157 related articles for article (PubMed ID: 25845810)
1. Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender difference.
Kreutz J; Vroonen L; Cattin F; Petrossians P; Thiry A; Rostomyan L; Tshibanda L; Beckers A; Bonneville JF
Neuroradiology; 2015 Jul; 57(7):679-84. PubMed ID: 25845810
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of extensive spherical amyloid deposits in a prolactin-secreting pituitary macroadenoma: a radiologic-pathologic correlation.
Levine SN; Ishaq S; Nanda A; Wilson JD; Gonzalez-Toledo E
Ann Diagn Pathol; 2013 Aug; 17(4):361-6. PubMed ID: 23602507
[TBL] [Abstract][Full Text] [Related]
3. T2-weighted magnetic resonance imaging characterization of prolactinomas and association with their response to dopamine agonists.
Burlacu MC; Maiter D; Duprez T; Delgrange E
Endocrine; 2019 Feb; 63(2):323-331. PubMed ID: 30267354
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging in the management of prolactinomas; a review of the evidence.
Varlamov EV; Hinojosa-Amaya JM; Fleseriu M
Pituitary; 2020 Feb; 23(1):16-26. PubMed ID: 31659622
[TBL] [Abstract][Full Text] [Related]
5. Gender-related differences in prolactin secretion in pituitary prolactinomas.
Nishioka H; Haraoka J; Akada K; Azuma S
Neuroradiology; 2002 May; 44(5):407-10. PubMed ID: 12012125
[TBL] [Abstract][Full Text] [Related]
6. Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study.
Delgrange E; Trouillas J; Maiter D; Donckier J; Tourniaire J
J Clin Endocrinol Metab; 1997 Jul; 82(7):2102-7. PubMed ID: 9215279
[TBL] [Abstract][Full Text] [Related]
7. Is a stable or decreasing prolactin level in a patient with prolactinoma a surrogate marker for lack of tumor growth?
Alkabbani AG; Mon SY; Hatipoglu B; Kennedy L; Faiman C; Weil RJ; Hamrahian AH
Pituitary; 2014 Apr; 17(2):97-102. PubMed ID: 23468127
[TBL] [Abstract][Full Text] [Related]
8. Growth potential of prolactinomas in men: is it really different from women?
Nishioka H; Haraoka J; Akada K
Surg Neurol; 2003 May; 59(5):386-90; discussion 390-1. PubMed ID: 12765811
[TBL] [Abstract][Full Text] [Related]
9. Hypopituitarism patterns among adult males with prolactinomas.
Peng J; Qiu M; Qi S; Li D; Peng Y
Clin Neurol Neurosurg; 2016 May; 144():112-8. PubMed ID: 27038873
[TBL] [Abstract][Full Text] [Related]
10. MRI--diagnostic and follow-up tool for microprolactinomas.
Seidl Z; Obenberger J; Marek J; Hána V; Vanĕcková M
Funct Neurol; 2000; 15(1):47-51. PubMed ID: 10842760
[TBL] [Abstract][Full Text] [Related]
11. Identification of an optimal prolactin threshold to determine prolactinoma size using receiver operating characteristic analysis.
Leca BM; Mytilinaiou M; Tsoli M; Epure A; Aylwin SJB; Kaltsas G; Randeva HS; Dimitriadis GK
Sci Rep; 2021 May; 11(1):9801. PubMed ID: 33963239
[TBL] [Abstract][Full Text] [Related]
12. [Prolactinoma in man: clinical and histological characteristics].
Trouillas J; Delgrange E; Jouanneau E; Maiter D; Guigard MP; Donckier J; Perrin G; Jan M; Tourniaire J
Ann Endocrinol (Paris); 2000 Sep; 61(3):253-7. PubMed ID: 10970951
[TBL] [Abstract][Full Text] [Related]
13. Prolactin-producing pituitary adenoma with abundant spherical amyloid deposition masquerading as extensive calcification.
Bakhtiar Y; Arita K; Hirano H; Habu M; Fujio S; Kitajima S; Tanimoto A
Neurol Med Chir (Tokyo); 2010; 50(11):1023-6. PubMed ID: 21123991
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred.
Burgess JR; Shepherd JJ; Parameswaran V; Hoffman L; Greenaway TM
J Clin Endocrinol Metab; 1996 Jul; 81(7):2642-6. PubMed ID: 8675591
[TBL] [Abstract][Full Text] [Related]
15. Salmon roe-like amyloid deposition in a prolactinoma: a case report.
Hassan T; Ikeda H; Yoshimoto T
Brain Tumor Pathol; 2003; 20(2):89-92. PubMed ID: 14756447
[TBL] [Abstract][Full Text] [Related]
16. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
Delgrange E; Sassolas G; Perrin G; Jan M; Trouillas J
Acta Neurochir (Wien); 2005 Jul; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
[TBL] [Abstract][Full Text] [Related]
17. Radiological Growth Patterns of Prolactinomas and Nonfunctioning Adenomas.
Imran SA; Shankar J; Hebb ALO; Croul SE; Clarke DB
Can J Neurol Sci; 2017 Sep; 44(5):508-513. PubMed ID: 28669359
[TBL] [Abstract][Full Text] [Related]
18. Spherical amyloid deposition in prolactinoma.
Gupta M; Grover N; Sen R
Indian J Pathol Microbiol; 2020; 63(3):491-492. PubMed ID: 32769350
[No Abstract] [Full Text] [Related]
19. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
Ma W; Ikeda H; Yoshimoto T
Cancer; 2002 Jul; 95(2):258-66. PubMed ID: 12124824
[TBL] [Abstract][Full Text] [Related]
20. The occurrence of macroscopical pituitary calcifications in prolactinomas.
Rasmussen C; Larsson SG; Bergh T
Neuroradiology; 1990; 31(6):507-11. PubMed ID: 2352634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
